REPORTS

Let’s Pullulate and Expand Your Business

Drug-Eluting Stents Market - Global Professional Analysis and Forecast to 2026

Feb 09, 2020  |  173 PAGES  |  REPORT CODE: CMM265960
  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • INDUSTRY COVERAGE

The worldwide Drug-Eluting Stents market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 11.2% during the forecast period.

This report presents the market size and development trends by detailing the Drug-Eluting Stents market revenue, market share and growth rate from 2015-2026, and it gives a thorough analysis by various product types, applications, regions, and main participants. The market conditions (2015-2019), corporate competition pattern, corporate SWOT analysis are elaborated, and other qualitative analyses like market dynamics, market penetration, market business environment analyses, the regional regulatory scenario in the Drug-Eluting Stents market will be shown in this report. In short, this report will comprehensively reveal the characteristics of Drug-Eluting Stents industry and will help you to build a panoramic view of the industrial development.

Drug-Eluting Stents Market, By Type:

  • Rapamycin

  • Paclitaxel

  • Everolimus

  • Others

Drug-Eluting Stents Market, By Application:

  • Angina Pectoris

  • Myocardial Infarction

Some of the leading players are as follows:

  • Lepu Medical

  • Cook Medical

  • Biotronik

  • Beijing AMSINO

  • Biosensors International

  • Liaoning Biomedical Materials R&D Center Co., Ltd. (LBC)

  • Sino Medical

  • Balton

  • Abbott

  • Shandong JW Medical

  • Medtronic, Inc.

  • MicroPort Scientific Corporation

  • Boston Scientific

  • Terumo

  • AlviMedica Medical Technologies

Geographically, Major regions are analyzed in details are as follows:

  • North America

  • Europe

  • Asia Pacific

  • Latin America

  • Middle East & Africa

Table of Contents

1 Methodology and Scope

  • 1.1 Market Segmentation & Scope

    • 1.1.1 Technology Type

    • 1.1.2 Product

    • 1.1.3 Application

    • 1.1.4 Regional scope

    • 1.1.5 Estimates and forecast timeline

  • 1.2 Research Methodology

  • 1.3 Information Procurement

    • 1.3.1 Purchased database

    • 1.3.2 Internal database

    • 1.3.3 Secondary sources

    • 1.3.4 Primary research

    • 1.3.5 Details of primary research

  • 1.4 Information or Data Analysis

    • 1.4.1 Data analysis models

  • 1.5 Market Formulation & Validation

  • 1.6 Model Details

    • 1.6.1 Commodity flow analysis

    • 1.6.2 Volume price analysis

  • 1.7 List of Secondary Sources

  • 1.8 List of Abbreviations

2 Executive Summary

  • 2.1 Market Outlook

  • 2.2 Segment Outlook

3 Market Variables, Trends, & Scope

  • 3.1 Market Lineage Outlook

  • 3.1.1 Parent market outlook

    • 3.1.2 Ancillary market outlook

  • 3.2 Market Segmentation

    • 3.2.1 Analysis

  • 3.3 Market Dynamics

    • 3.3.1 Market driver analysis

    • 3.3.2 Market restraint analysis

    • 3.3.3 Industry opportunities

  • 3.4 Penetration & Growth Prospect Mapping

    • 3.4.1 Penetration & growth prospect mapping analysis

  • 3.5 Business Environment Analysis Tools

    • 3.5.1 Porter's five forces analysis

    • 3.5.2 PESTLE analysis

    • 3.5.3 Major deals & strategic alliances analysis

4 Drug-Eluting Stents Market: Technology Type Analysis

  • 4.1 Drug-Eluting Stents Technology Type Market Share Analysis, 2018 & 2026

  • 4.2 Drug-Eluting Stents Technology Type Market: Segment Dashboard

  • 4.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Technology Type Segment

    • 4.3.1 Rapamycin

    • 4.3.2 Paclitaxel

    • 4.3.3 Everolimus

    • 4.3.4 Others

5 Drug-Eluting Stents Market: Product Analysis

  • 5.1 Drug-Eluting Stents Product Market Share Analysis, 2018 & 2026

  • 5.2 Drug-Eluting Stents Product Market: Segment Dashboard

  • 5.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Product Segment

6 Drug-Eluting Stents Market: Application Analysis

  • 6.1 Drug-Eluting Stents Application Market Share Analysis, 2018 & 2026

  • 6.2 Drug-Eluting Stents Application Market: Segment Dashboard

  • 6.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Application Segment

    • 6.3.1 Angina Pectoris

    • 6.3.2 Myocardial Infarction

7 Drug-Eluting Stents Market: Regional Analysis

  • 7.1 Drug-Eluting Stents Regional Market Share Analysis, 2018 & 2026

  • 7.2 Drug-Eluting Stents Regional Market: Segment Dashboard

  • 7.3 Regional Market Snapshot (Market Size, CAGR, Top Countries)

  • 7.4 List of Players at Regional Level

    • 7.4.1 North America

    • 7.4.2 Europe

    • 7.4.3 Asia Pacific

  • 7.5 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)

    • 7.5.1 North America

    • 7.5.2 Europe

    • 7.5.3 Asia Pacific

    • 7.5.4 Latin America

    • 7.5.5 MEA

  • 7.6 Market Size & Forecasts, and Trend Analysis, 2015 to 2026

    • 7.6.1 North America

    • 7.6.2 Europe

    • 7.6.3 Asia Pacific

    • 7.6.4 Latin America

    • 7.6.5 Middle East & Africa

8 Competitive Analysis

  • 8.1 Recent Developments & Impact Analysis, by Key Market Participants

  • 8.2 Strategic Framework/Competition Categorization (Key innovators, Market leaders, Emerging players)

  • 8.3 Vendor Landscape

    • 8.3.1 Company market position analysis (Geographic presence, service portfolio, strategic initiatives)

9 Company Profiles

  • 9.1 Lepu Medical

    • 9.1.1 Lepu Medical Company overview

    • 9.1.2 Financial performance

    • 9.1.3 Product benchmarking

    • 9.1.4 Strategic initiatives

    • 9.1.5 SWOT analysis

  • 9.2 Cook Medical

    • 9.2.1 Cook Medical Company overview

    • 9.2.2 Financial performance

    • 9.2.3 Product benchmarking

    • 9.2.4 Strategic initiatives

    • 9.2.5 SWOT analysis

  • 9.3 Biotronik

    • 9.3.1 Biotronik Company overview

    • 9.3.2 Financial performance

    • 9.3.3 Product benchmarking

    • 9.3.4 Strategic initiatives

    • 9.3.5 SWOT analysis

  • 9.4 Beijing AMSINO

    • 9.4.1 Beijing AMSINO Company overview

    • 9.4.2 Financial performance

    • 9.4.3 Product benchmarking

    • 9.4.4 Strategic initiatives

    • 9.4.5 SWOT analysis

  • 9.5 Biosensors International

    • 9.5.1 Biosensors International Company overview

    • 9.5.2 Financial performance

    • 9.5.3 Product benchmarking

    • 9.5.4 Strategic initiatives

    • 9.5.5 SWOT analysis

  • 9.6 Liaoning Biomedical Materials R&D Center Co., Ltd. (LBC)

    • 9.6.1 Liaoning Biomedical Materials R&D Center Co., Ltd. (LBC) Company overview

    • 9.6.2 Financial performance

    • 9.6.3 Product benchmarking

    • 9.6.4 Strategic initiatives

    • 9.6.5 SWOT analysis

  • 9.7 Sino Medical

    • 9.7.1 Sino Medical Company overview

    • 9.7.2 Financial performance

    • 9.7.3 Product benchmarking

    • 9.7.4 Strategic initiatives

    • 9.7.5 SWOT analysis

  • 9.8 Balton

    • 9.8.1 Balton Company overview

    • 9.8.2 Financial performance

    • 9.8.3 Product benchmarking

    • 9.8.4 Strategic initiatives

    • 9.8.5 SWOT analysis

  • 9.9 Abbott

    • 9.9.1 Abbott Company overview

    • 9.9.2 Financial performance

    • 9.9.3 Product benchmarking

    • 9.9.4 Strategic initiatives

    • 9.9.5 SWOT analysis

  • 9.10 Shandong JW Medical

    • 9.10.1 Shandong JW Medical Company overview

    • 9.10.2 Financial performance

    • 9.10.3 Product benchmarking

    • 9.10.4 Strategic initiatives

    • 9.10.5 SWOT analysis

  • 9.11 Medtronic, Inc.

    • 9.11.1 Medtronic, Inc. Company overview

    • 9.11.2 Financial performance

    • 9.11.3 Product benchmarking

    • 9.11.4 Strategic initiatives

    • 9.11.5 SWOT analysis

  • 9.12 MicroPort Scientific Corporation

    • 9.12.1 MicroPort Scientific Corporation Company overview

    • 9.12.2 Financial performance

    • 9.12.3 Product benchmarking

    • 9.12.4 Strategic initiatives

    • 9.12.5 SWOT analysis

  • 9.13 Boston Scientific

    • 9.13.1 Boston Scientific Company overview

    • 9.13.2 Financial performance

    • 9.13.3 Product benchmarking

    • 9.13.4 Strategic initiatives

    • 9.13.5 SWOT analysis

  • 9.14 Terumo

    • 9.14.1 Terumo Company overview

    • 9.14.2 Financial performance

    • 9.14.3 Product benchmarking

    • 9.14.4 Strategic initiatives

    • 9.14.5 SWOT analysis

  • 9.15 AlviMedica Medical Technologies

    • 9.15.1 AlviMedica Medical Technologies Company overview

    • 9.15.2 Financial performance

    • 9.15.3 Product benchmarking

    • 9.15.4 Strategic initiatives

    • 9.15.5 SWOT analysis

 

The List of Tables and Figures (Totals 111 Figures and 146 Tables)

  • Figure Rapamycin Drug-Eluting Stents market, 2015 - 2026 (USD Million)

  • Figure Paclitaxel Drug-Eluting Stents market, 2015 - 2026 (USD Million)

  • Figure Everolimus Drug-Eluting Stents market, 2015 - 2026 (USD Million)

  • Figure Others Drug-Eluting Stents market, 2015 - 2026 (USD Million)

  • Figure Angina Pectoris market, 2015 - 2026 (USD Million)

  • Figure Myocardial Infarction market, 2015 - 2026 (USD Million)

  • Table List of players in North America

  • Table List of players in Europe

  • Table List of players in Asia Pacific

  • Table SWOT analysis

  • Table North America Drug-Eluting Stents market, by country, 2015 - 2026 (USD Million)

  • Table North America Drug-Eluting Stents market, by type, 2015 - 2026 (USD Million)

  • Table North America Drug-Eluting Stents market, by product, 2015 - 2026 (USD Million)

  • Table North America Drug-Eluting Stents market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table U.S. Drug-Eluting Stents market, by type, 2015 - 2026 (USD Million)

  • Table U.S. Drug-Eluting Stents market, by product, 2015 - 2026 (USD Million)

  • Table U.S. Drug-Eluting Stents market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Canada Drug-Eluting Stents market, by type, 2015 - 2026 (USD Million)

  • Table Canada Drug-Eluting Stents market, by product, 2015 - 2026 (USD Million)

  • Table Canada Drug-Eluting Stents market, by application, 2015 - 2026 (USD Million)

  • Table Europe Drug-Eluting Stents market, by country, 2015 - 2026 (USD Million)

  • Table Europe Drug-Eluting Stents market, by type, 2015 - 2026 (USD Million)

  • Table Europe Drug-Eluting Stents market, by product, 2015 - 2026 (USD Million)

  • Table Europe Drug-Eluting Stents market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table U.K. Drug-Eluting Stents market, by type, 2015 - 2026 (USD Million)

  • Table U.K. Drug-Eluting Stents market, by product, 2015 - 2026 (USD Million)

  • Table U.K. Drug-Eluting Stents market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Germany Drug-Eluting Stents market, by type, 2015 - 2026 (USD Million)

  • Table Germany Drug-Eluting Stents market, by product, 2015 - 2026 (USD Million)

  • Table Germany Drug-Eluting Stents market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table France Drug-Eluting Stents market, by type, 2015 - 2026 (USD Million)

  • Table France Drug-Eluting Stents market, by product, 2015 - 2026 (USD Million)

  • Table France Drug-Eluting Stents market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Italy Drug-Eluting Stents market, by type, 2015 - 2026 (USD Million)

  • Table Italy Drug-Eluting Stents market, by product, 2015 - 2026 (USD Million)

  • Table Italy Drug-Eluting Stents market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Spain Drug-Eluting Stents market, by type, 2015 - 2026 (USD Million)

  • Table Spain Drug-Eluting Stents market, by product, 2015 - 2026 (USD Million)

  • Table Spain Drug-Eluting Stents market, by application, 2015 - 2026 (USD Million)

  • Table Asia Pacific Drug-Eluting Stents market, by country, 2015 - 2026 (USD Million)

  • Table Asia Pacific Drug-Eluting Stents market, by type, 2015 - 2026 (USD Million)

  • Table Asia Pacific Drug-Eluting Stents market, by product, 2015 - 2026 (USD Million)

  • Table Asia Pacific Drug-Eluting Stents market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table China Drug-Eluting Stents market, by type, 2015 - 2026 (USD Million)

  • Table China Drug-Eluting Stents market, by product, 2015 - 2026 (USD Million)

  • Table China Drug-Eluting Stents market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Japan Drug-Eluting Stents market, by type, 2015 - 2026 (USD Million)

  • Table Japan Drug-Eluting Stents market, by product, 2015 - 2026 (USD Million)

  • Table Japan Drug-Eluting Stents market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table India Drug-Eluting Stents market, by type, 2015 - 2026 (USD Million)

  • Table India Drug-Eluting Stents market, by product, 2015 - 2026 (USD Million)

  • Table India Drug-Eluting Stents market, by application, 2015 - 2026 (USD Million)

  • Table Latin America Drug-Eluting Stents market, by country, 2015 - 2026 (USD Million)

  • Table Latin America Drug-Eluting Stents market, by type, 2015 - 2026 (USD Million)

  • Table Latin America Drug-Eluting Stents market, by product, 2015 - 2026 (USD Million)

  • Table Latin America Drug-Eluting Stents market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Brazil Drug-Eluting Stents market, by type, 2015 - 2026 (USD Million)

  • Table Brazil Drug-Eluting Stents market, by product, 2015 - 2026 (USD Million)

  • Table Brazil Drug-Eluting Stents market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Mexico Drug-Eluting Stents market, by type, 2015 - 2026 (USD Million)

  • Table Mexico Drug-Eluting Stents market, by product, 2015 - 2026 (USD Million)

  • Table Mexico Drug-Eluting Stents market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Argentina Drug-Eluting Stents market, by type, 2015 - 2026 (USD Million)

  • Table Argentina Drug-Eluting Stents market, by product, 2015 - 2026 (USD Million)

  • Table Argentina Drug-Eluting Stents market, by application, 2015 - 2026 (USD Million)

  • Table MEA Drug-Eluting Stents market, by country, 2015 - 2026 (USD Million)

  • Table MEA Drug-Eluting Stents market, by type, 2015 - 2026 (USD Million)

  • Table MEA Drug-Eluting Stents market, by product, 2015 - 2026 (USD Million)

  • Table MEA Drug-Eluting Stents market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table South Africa Drug-Eluting Stents market, by type, 2015 - 2026 (USD Million)

  • Table South Africa Drug-Eluting Stents market, by product, 2015 - 2026 (USD Million)

  • Table South Africa Drug-Eluting Stents market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Nigeria Drug-Eluting Stents market, by type, 2015 - 2026 (USD Million)

  • Table Nigeria Drug-Eluting Stents market, by product, 2015 - 2026 (USD Million)

  • Table Nigeria Drug-Eluting Stents market, by application, 2015 - 2026 (USD Million)

  • Table Recent Developments & Impact Analysis, by Key Market Participants

  • Table Recent Developments & Impact Analysis, by Key Market Participants

  • Table Company market position analysis

  • Table Company Profiles

  • Table Lepu Medical Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Cook Medical Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Biotronik Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Beijing AMSINO Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Biosensors International Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Liaoning Biomedical Materials R&D Center Co., Ltd. (LBC) Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Sino Medical Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Balton Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Abbott Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Shandong JW Medical Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Medtronic, Inc. Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table MicroPort Scientific Corporation Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Boston Scientific Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Terumo Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table AlviMedica Medical Technologies Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

Report Purchase

reports
$3850
$7700
BUY NOWClick MeBUY NOW
top